{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:43Z","timestamp":1786991143268,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jaad.2020.05.090","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:32:00Z","timestamp":1590096720000},"page":"1360-1366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["New-onset depression among children, adolescents, and adults with hidradenitis suppurativa"],"prefix":"10.1016","volume":"83","author":[{"given":"Shari","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2020.05.090_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12788\/j.sder.2017.024","article-title":"Major gaps in understanding and treatment of hidradenitis suppurativa","volume":"36","author":"Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2020.05.090_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.jaad.2020.05.090_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jaad.2015.07.054","article-title":"The psychosocial impact of hidradenitis suppurativa","volume":"73","author":"Gooderham","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.05.090_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/PROM.S174299","article-title":"An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa","volume":"11","author":"MacMahon","year":"2020","journal-title":"Patient Relat Outcome Meas"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1373\/49.4.624","article-title":"LOINC, a universal standard for identifying laboratory observations: a 5-year update","volume":"49","author":"McDonald","year":"2003","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.090_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000468148","article-title":"Validation of a case-finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database","volume":"233","author":"Strunk","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.05.090_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12888-014-0289-5","article-title":"Systematic review and assessment of validated case definitions for depression in administrative data","volume":"14","author":"Fiest","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.jaad.2020.05.090_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-\u03b1 in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-\u03b1 agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti\u2013IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.090_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"Xu","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaad.2020.05.090_bib14","doi-asserted-by":"crossref","first-page":"2450401","DOI":"10.1155\/2017\/2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10.1016\/j.jaad.2020.05.090_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000490002","article-title":"Inflammation: a contributor to depressive comorbidity in inflammatory skin disease","volume":"31","author":"Farzanfar","year":"2018","journal-title":"Skin Pharmacol Physiol"},{"issue":"12","key":"10.1016\/j.jaad.2020.05.090_bib16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamadermatol.2017.3596","article-title":"Association of resilience with depression and health related quality of life for patients with hidradenitis suppurativa","volume":"153","author":"Kirby","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.05.090_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2020.05.090_bib18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.05.090_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.05.090_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.05.090_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jamadermatol.2015.4593","article-title":"Factors associated with point-of-care treatment decisions for hidradenitis suppurativa","volume":"152","author":"Garg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.05.090_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.05.090_bib24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.090_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","article-title":"Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity","volume":"61","author":"Canoui-Poitrine","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.05.090_bib26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.05.090_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.05.090_bib28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","article-title":"Incidence of long-term opioid use among opioid-naive patients with hidradenitis suppurativa in the United States","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.05.090_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.090_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jid.2017.06.020","article-title":"Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study","volume":"138","author":"Huilaja","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modeling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjd.16998","article-title":"Prevalence of self-reported hidradenitis suppurativa patients in a cohort of Danish blood donors: a cross-sectional study","volume":"180","author":"Theut Riis","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.05.090_bib33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaad.2018.02.067","article-title":"Somatic and psychiatric comorbidities of hidradenitis suppurativa in\u00a0children and adolescents","volume":"79","author":"Tiri","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.05.090_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.05.090_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"303","key":"10.1016\/j.jaad.2020.05.090_bib36","first-page":"1","article-title":"Prevalence of depression among adults aged 20 and over: United States, 2013\u20132016","author":"Brody","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"7","key":"10.1016\/j.jaad.2020.05.090_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/08039488.2013.877074","article-title":"Prevalence of depression, quality of life and antidepressant treatment in the Danish General Suburban Population Study","volume":"68","author":"Ellervik","year":"2014","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/j.jaad.2020.05.090_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.0001-690X.2003.00231.x","article-title":"Prevalence of major depression and stress indicators in the Danish general population","volume":"108","author":"Olsen","year":"2004","journal-title":"Acta Psychiatr Scand"},{"issue":"535","key":"10.1016\/j.jaad.2020.05.090_bib39","first-page":"144","article-title":"Do ultra-short screening instruments accurately detect depression in primary care?","volume":"57","author":"Mitchell","year":"2007","journal-title":"Br J Gen Pract"},{"issue":"7","key":"10.1016\/j.jaad.2020.05.090_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1525-1497.1997.00076.x","article-title":"Case-finding instruments for depression. Two questions are as good as many","volume":"12","author":"Whooley","year":"1997","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2020.05.090_bib41","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1542\/peds.2009-2712","article-title":"Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents","volume":"125","author":"Richardson","year":"2010","journal-title":"Pediatrics"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220309609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220309609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:56:38Z","timestamp":1759272998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220309609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0190962220309609"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.090","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New-onset depression among children, adolescents, and adults with hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}